| Labatec Pharma SA - Bijuva 1 mg / 100 mg, capsule molle | | 68971 | | 01 | | Bijuva 1 mg / 100 mg | | capsule molle | | G03FA04 | | Progesterone and Estrogen | | 04.04.2024 | | |
| | Composition | | estradiolum 1.0 mg ut estradiolum hemihydricum, progesteronum 100.0 mg, glyceroli mono/dicaprylocapras, macrogolglyceridorum laurates, matériel de la capsule: gelatina, gelatina hydrolysata, glycerolum, E 129, titanii dioxidum, triglycerida media, phosphatidylcholinum, encre: propylenglycolum, titanii dioxidum, polyvinylis acetas phtalas, macrogolum, pro capsula. | | Packungsbestandteile | | capsule molle | | | | Active Agent | Dose |
|---|
| Estradiol | 1 mg | | Progesterone | 100 mg |
| | | | Inactive agents | | additional_information |
|---|
| E 129 | | color. | | Gelatina | | matériel de la capsule | | Gelatina Hydrolysata | | | | Glyceroli Mono/dicaprylocapras | | | | Glycerol | | | | Macrogolglyceridorum Laurates | | | | Macrogol | | | | Phosphatidylcholine | | | | Polyvinylis Acetas Phtalas | | | | Pro Capsula | | | | Propylenglycol | | encre | | Titanium Dioxide | | | | Triglycerida Media | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 28 | PR | PR | B | | No |
|
|
